Aurobindo Pharma gets shareholders’ nod to raise up to $600 million
The funds will facilitate and meet the additional capital expenditure requirements for the ongoing and future projects of the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Aurobindo Pharma
Aurobindo Pharma receives US FDA approval for allergic conjunctivitis solution
The approved product has an estimated market size of $235 million
Aurobindo Pharma receives USFDA approval for methylprednisolone sodium succinate injection
The approved product has an estimated market size of $102 million for the twelve months ending October 2015 according to IMS…
Aurobindo Pharma receives US FDA approval for tramadol hydrochloride extended-release tabs
Tramadol hydrochloride tabs are used in the treatment of moderate-to-severe pain in adults
Aurobindo Pharma has received final…
Aurobindo Pharma receives US FDA Approval for Alzheimer’s drug
The approved product has an estimated market size of $1.23 billion according to IMS
Aurobindo Pharma has received the final…
Aurobindo Pharma’s Telangana unit gets nod from green panel
Based on the recommendations of the Expert Appraisal Committee (EAC), the ministry gave final green nod to the 'A' category…
Aurobindo Pharma receives US FDA approval for Telmisartan tabs
Telmisartan tablets are indicated in the treatment of essential hypertension
Aurobindo gets US FDA nod for hepatitis B drug
Entecavir tablets are indicated for treatment of chronic hepatitis B virus infection of the liver
Aurobindo Pharma has received…
Aurobindo Pharma receives US FDA approval for Omeprazole delayed-release capsules
Omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults
Aurobindo Pharma posts Rs 3320.4-crore total operating income at Q1/FY2015-16
Profit after tax after minority interest was at Rs 432.4 crores
Aurobindo Pharma has posted the unaudited consolidated financial…